Veracyte, Inc.
VCYT
$26.64
-$0.055-0.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 478.06% | 118.07% | 151.17% | 168.25% | 76.96% |
| Total Depreciation and Amortization | -4.08% | -1.31% | -19.73% | -16.34% | -16.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.76% | -51.89% | -76.27% | 4.30% | 4.42% |
| Change in Net Operating Assets | 32.61% | -394.32% | 94.13% | -9.62% | -118.25% |
| Cash from Operations | 159.80% | 57.69% | 111.44% | 77.40% | -312.80% |
| Capital Expenditure | 14.76% | -65.84% | 19.99% | 24.50% | -114.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,900.49% | -2,068.24% | 19.99% | 24.50% | -88.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -0.03% | 84.20% | 387.83% | 0.31% | -25.09% |
| Repurchase of Common Stock | -146.63% | -190.51% | 10.87% | -46.24% | -68.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -650.46% | -799.22% | 9,253.64% | -102.77% | -151.28% |
| Foreign Exchange rate Adjustments | 168.52% | -235.02% | 182.49% | -771.43% | -316.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -648.81% | -346.68% | 237.60% | 99.62% | -129.86% |